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Abstract
Ischemia and reperfusion (I/R) of the heart is associated with biochemical
and ionic changes that result in cardiac contractile and electrical dysfunction.
In rabbits, platelet-rich plasma activated using nanosecond pulsed electric
fields (nsPRP) has been shown to improve left ventricular pumping. Here, we
demonstrate that nsPRP causes a similar improvement in mouse left ventricu-
lar function. We also show that nsPRP injection recovers electrical activity
even before reperfusion begins. To uncover the mechanism of nsPRP action,
we studied whether the enhanced left ventricular function in nsPRP rabbit
and mouse hearts was associated with increased expression of heat-shock pro-
teins and altered mitochondrial function under conditions of oxidative stress.
Mouse hearts underwent 30 min of global ischemia and 1 h of reperfusion
in situ. Rabbit hearts underwent 30 min of ischemia in vivo and were reper-
fused for 14 days. Hearts treated with nsPRP expressed significantly higher
levels of Hsp27 and Hsp70 compared to hearts treated with vehicle. Also, pre-
treatment of cultured H9c2 cells with nsPRP significantly enhanced the “spare
respiratory capacity (SRC)” also referred to as “respiratory reserve capacity”
and ATP production in response to the uncoupler FCCP. These results sug-
gest a cardioprotective effect of nsPRP on the ischemic heart during reperfu-
sion.
Introduction
The term ‘’ischemic–reperfusion injury” describes several
types of myocardial dysfunction inclusive of, but not lim-
ited to: (1) myocardial stunning, which is reversible and
is manifested by mechanical dysfunction after ischemia
and the restoration of blood flow (Heyndrickx et al.
1975) (generally, there is no evidence of cell necrosis) and
(2) no-flow ischemia, which occurs when there is
microvascular obstruction presenting as tissue compres-
sion, endothelial and myocyte swelling, and neutrophil
infiltration, resulting in the inability to completely perfuse
the ischemic area. Cardiac necrosis is present along with
ventricular arrhythmias (Kloner et al. 1980). Ischemia
and reperfusion (I/R) of the heart is associated with bio-
chemical and ionic changes that result in cardiac contrac-
tile and electrical dysfunction (Carmeliet 1999). While
there are several effective therapeutic methods for
re-establishing blood flow to the ischemic heart (Tiefen-
brunn and Sobel 1992; Rogers et al. 1994), no such thera-
peutic intervention exists to protect and treat damaged
cardiac myocytes secondary to I/R.
There are various forms of metabolic stress that predis-
pose I/R cardiomyocytes to damage. One of the best
described mechanisms of I/R injury is oxidative stress,
resulting from the formation of reactive oxygen species
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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(ROS). Elevated ROS levels can cause oxidative damage
to the cells they encounter (Miller and Cheung 2015).
During early reperfusion the mitochondrial electron
chain, activated neutrophils, cardiac myocytes, and
endothelial cells are all sources of ROS production (Bar-
andier et al. 1999; Park and Lucchesi 1999; Hoffman
et al. 2004). Under physiologic conditions, ROS produced
from these sources are detoxified by endogenous antioxi-
dants (Hoffman et al. 2004). However, under conditions
of I/R, when the increase in ROS levels exceeds the capac-
ity of the endogenous scavenging mechanisms, cell dam-
age can occur (Hoffman et al. 2004).
During cardiac ischemia there is an insufficient avail-
ability of oxygen for mitochondria to carry out oxidative
metabolic reactions. As a result, there is an approximate
65% decrease in ATP levels after 15 min of ischemia and
a 90% decrease after 40 min (Reimer and Jennings 1986).
We have previously demonstrated that platelet-rich
plasma (PRP) prepared using nanosecond pulsed electric
fields (nsPRP) to activate the platelets, reduces ROS levels
in cultured H9c2 (Rattus norvegicus) and HUVEC (hu-
man umbilical vein endothelial) cells stimulated with
H2O2 (Hargrave 2014). We have also reported that nsPRP
contains significant concentrations of the antioxidants
catalase (CAT) and superoxide dismutase (SOD) (Har-
grave 2014), something that we did not observe in PRP
activated with the conventional bovine thrombin as the
platelet activator (Hargrave 2014). These observations
provide evidence in support of an effect of nsPRP on
ROS levels and on CAT and SOD, and suggest that the
method used for the preparation of PRP may be impor-
tant. More importantly, these data led us to propose that
lower ROS levels may contribute to the enhanced left
ventricular function that we (Hargrave and Francis 2012)
and others (Cheng et al. 2012) previously observed
in vivo and in situ in the rabbit and rat I/R heart models.
Here, we show that nsPRP enhances LV function in mice
and that it also partially restores electrical activity (in rab-
bit). We previously reported that ischemic–reperfused
rabbit hearts treated with nsPRP had improved LV func-
tion under dobutamine stress and that infarct size was
smaller (Hargrave and Francis 2012). To investigate the
mechanisms by which nsPRP improves LV function, we
measured the expression of the cardioprotective heat-
shock proteins Hsp 27 and Hsp70 in vivo in rabbit tissue
and the mitochondrial spare respiratory capacity in cul-
tured H9c2 cells.
Materials and Methods
Animal experimentation was approved by the Institu-
tional Animal Care and Use Committee at Old Dominion
University and was conducted in accordance with the
Guide to the Care and Use of Laboratory Animals (NIH
publication). Nine adult female mice and 16 adult female
New Zealand white (NZW) rabbits were studied.
Ischemia–reperfusion in vivo rabbit heart
model
The surgical preparation for the in vivo rabbit I/R model
has been described by Hargrave and Francis (2012).
Briefly, eight New Zealand white rabbits (Harlan, Inc.,
Frederick, Maryland) were sedated with a combination of
acepromazine (2 mg/kg) and ketamine (25 mg/kg) and
intubated using a pediatric endotracheal tube size 3. Once
the endotracheal tube was in place, general anesthesia was
induced using isoflurane in oxygen (5%–5 L/min for
1 min then 1.5%–1.5 L/min for the duration of the pro-
cedure). The endotracheal tube was attached to a Harvard
respirator and the animal ventilated at 50 breaths/minute
using a nonrebreathing circuit.
The left thoracic area was shaved and cleansed with
70% ethanol and chlorhex-Q scrub. Once a surgical plane
of anesthesia was established, the animal was surgically
prepared for the creation of ischemia and reperfusion by
performing a left thoracotomy and pericardiotomy. To
make the heart ischemic, the distal branch of the left
anterior descending artery was transiently occluded by
placing a 5-0-prolene suture around the distal segment of
the vessel. The coronary vessel was occluded for 30 min
by placing tension on the suture. Ten minutes before
release of the occlusion and the start of reperfusion,
200 lL of nsPRP supernatant or 200 lL saline was
injected directly into the myocardium of the left ventricle
at the level of the infarcted tissue using a sterile 25-G 1/
2-inch needle. After all injections were made, the thoracic
cavity was closed and care was taken to remove excess air
from the cavity to prevent the development of a pneu-
mothorax. An angiocath (16 G) was used as a chest tube
to remove air from the chest cavity. The chest tube was
then removed. Once the chest was closed and the incision
sutured, the isoflurane was stopped and the animal was
allowed to breathe room air. The endotracheal tube was
removed when there were signs that the animal was
breathing comfortably without the ventilator. All animals
were returned to their housing facility for 14 days.
Measurement of left ventricle mechanical function
in vivo during dobutamine stress test
Fourteen days after coronary occlusion and reperfusion,
general anesthesia was again induced with isoflurane and
oxygen as described previously (Hargrave and Francis
2012). A midline incision was made over the trachea
and the left carotid artery exposed. A Millar Probe
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Catheter-Model SPR 524 (Millar Instruments, Houston,
Texas) was gently passed into the left ventricle via the caro-
tid artery for the measurement of left ventricular pressures,
heart rate, and positive and negative dp/dt. A 25-G catheter
was placed into the marginal ear vein for the administra-
tion of dobutamine (5, 10, and 20 lg/kg/min), which was
used as a stressor. The dobutamine (Sigma-Aldrich, St.
Louis, Missouri) dose was increased every 3 min until the
maximum dose was achieved. Data were collected for
60 min after the maximal dobutamine dose was reached.
Mouse Langendorff heart preparation
Nine female adult mice (Swiss Webster, Charles Rivers
Laboratory) were studied. A surgical plane of anesthesia
was induced by allowing the animal to breathe isoflurane
and oxygen. As we described previously (Hargrave and
Francis 2012), a thoracic incision was made and the
mouse heart was quickly removed and placed into a mod-
ified Tyrode’s solution chilled to 0–4°C and mounted
with the following modifications. The heart was mounted
onto a 22-G 1/2-inch flanged stainless steel cannula. A
Millar catheter (Millar Instruments, Houston, Texas)
which was attached to a pressure transducer was inserted
into the left ventricle. Left ventricular positive dP/dt was
recorded every 10 sec through a polyvinyl catheter using
a COBE CDX III transducer and Micro-Med 100 Blood
Pressure Analyzer (Louisville, Kentucky) software. The
preparation was allowed to beat spontaneously and per-
mitted to equilibrate for 10 min prior to the initiation of
the experimental protocol. nsPRP supernatant or vehicle
(0.9% NaCl) injections were made into the myocardium
of the left ventricle using a 27-G 1/2-inch needle. In each
case, the volume of the injectate was 50 lL.
H9c2 cell culture
H9c2 (Rattus norvegicus; cardiac myoblast) cells (CRL-
1446, ATCC; Manassas, Virginia), were grown in sterile
75 cm2 flasks at 37°C and 5% atmospheric CO2 as
described previously (Hargrave 2014). Briefly, cell culture
media consisted of 15 mL Dulbecco’s modified Eagle’s
mediumTM (Mediatech, Inc., Manassas, Virginia) contain-
ing 10% fetal bovine serum (FBS, Atlanta Biologicals,
Inc., Lawrenceville, Georgia). Once the cells reached 85–
95% confluency, approximately 1.05 9 105 cells/mL were
transferred onto a sterile multiwell culture plate (Corn-
ing) and treated with 200 lL of ns-PEF-activated PRP in
1 mL of cell culture media [1.05 mg/75 cm2 flask] or cell
culture media only. The cells were then returned to the
incubator for 24 h. For the measurement of ROS, cells
were loaded with 20 lmol/L CM-H2DCFDA as per the
manufacturer’s instructions (Invitrogen–Molecular
Probes, Eugene, Oregon). ROS formation was measured
using flow cytometry (BD FACSAria Cell Sorter, San Jose,
California).
Nanosecond pulse electric field (nsPEF) and the
pulse generator
Nanosecond pulse electric fields are ultrashort pulsed
electric fields, typically with high field strength that affects
intracellular as well as extracellular membranous struc-
tures and functions (Schoenbach et al. 2007; Zhang et al.
2008). Nanosecond pulses convey intense, high power,
but low-energy electric fields. During platelet activation,
nsPEFs charge the platelet membrane, and create pores
without inducing permanent damage (Schoenbach et al.
2007; Zhang et al. 2008). The 300 nsec pulse generator
used for these studies has been described previously
(Schoenbach et al. 2007; Zhang et al. 2008). The electrical
pulses were applied to PRP in sterile aluminum electropo-
ration cuvettes having an electrode gap of 0.4 cm and an
area of 1 cm2. The shape and amplitude of the pulse volt-
age was monitored using a 500-MHz oscilloscope. For the
generation of nsPRP, one milliliter of PRP in the presence
of 10 mmol/L CaCl2 was exposed to 5 pulses at an elec-
tric field of 30 kV/cm.
Preparation of nsPRP supernatant
We prepared the nsPRP supernatant as described previ-
ously by Hargrave (2014). Briefly, the platelet concentrate
was exposed to 5 pulses at an electric field of 30 kV/cm.
Transfection of H9c2 cells in culture with siRNA
Hsp 70
H9c2 cells were exposed to either an Hsp70 siRNA or an
irrelevant control siRNA, and then pretreated with nsPRP
or vehicle for 24 h followed by stimulation with H2O2.
The cells were loaded with CM-H2DCFDA, a ROS dye
indicator, and analyzed using flow cytometry.
Western blot analysis
We evaluated the effect of nsPRP on the expression of the
Hsp70 and Hsp27 in the left ventricular rabbit tissue
using western blot analysis. In this in vivo study, the
hearts were made ischemic by placing a suture around
the distal 1/3 of the left anterior descending (LAD) coro-
nary artery and occluding blood flow for 30 min. The
suture was removed and the tissue allowed to reperfuse.
The chest was closed and the animals maintained for
14 days. On day 14, the LV was separated from the rest
of the heart and frozen on dry ice and stored at 80°C
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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until analysis. On the day of analysis, the tissue was
homogenized and the proteins were isolated using RIPA
buffer. The protein concentration was determined by the
BCA protein method according to the manufacturer’s
instructions (Thermo Fisher Scientific, Rockford, Illinois).
Protein-matched samples (40 lg per lane) were separated
by electrophoresis through 12% sodium dodecyl sulfate
(SDS-PAGE) Tris HCl gels. Wet transfer was used to
transfer the proteins onto nitrocellulose membranes. The
membranes were incubated for 1 h at room temperature
in 5% nonfat dry milk in Tris-buffered saline–0.1% (vol/
vol) Tween 20 (blocking buffer). The membranes were
then incubated at 4°C overnight with the appropriate
Hsp27 (#2402), pHsp27 (#2401), Hsp70 (#4872) antibod-
ies from Cell Signaling (Danvers, Massachusetts), and
Hsp90 antibody (#624088) from BD Transductions Labo-
ratories (San Jose, California). All the antibodies were
diluted 1/1000 (vol/vol) in blocking buffer. The next day
and after a 1 h incubation of the membranes with the
corresponding secondary antibodies (LI-COR, Lincoln,
Nebraska) protein expression was visualized using an
Odyssey 9120 Infrared Imaging System (LI-COR, Lincoln,
Nebraska). Hsp90 was used as the loading control.
Densitometry/statistical analysis
Image J software (National Institutes of Health) was used
to perform densitometry of immunoblots. All data are
expressed as mean values  SE (standard error of mean).
Student’s t test was performed to determine statistically
significant differences between the two groups. A value of
P < 0.05 was considered significant. GraphPad Prism 4
(version 4.03, Graph Pad Software) was used for data
analysis; n represents the number of experimental repeats.
Optical mapping Langendorff perfusion
The optical mapping setup is shown in Figure 5A and
has been previously described by Zemlin et al. (2008).
Briefly, the heart was surgically removed as described
previously and placed in the main chamber of a life
support system. It was perfused retrogradely through the
aorta with Tyrode solution (in mmol: NaCl 130, KCl
4.0, CaCl2 1.8, MgCl2 1.0, NaHCO3 24, NaH2PO4 1.2,
glucose 5.6), at a pressure of 60–80 mmHg, maintained
by adjusting the perfusion flow rate. The solution was
bubbled with a gas mixture of 95% oxygen and 5% CO2
and the pH maintained at 7.4. The main chamber was
further superfused with the same oxygenized Tyrode
solution to keep the temperature of the heart and the
surrounding bath at 37  0.5°C. A pressure transducer
(TD1000, Transducer Direct) was connected very close to
the aorta and resultant pressure signal was continuously
sampled by a data acquisition board, displayed, and
recorded. Optical mapping of transmembrane voltage
(Vm) was performed. In each case, the motion of the
heart was interrupted by adding 5–10 mmol/L blebbis-
tatin (Grinvald et al. 1982; Fedorov et al. 2007), and
the heart was loaded with a fluorescent dye. The heart
was illuminated with diffused laser light of appropriate
wavelength. The fluorescent light was filtered through
an appropriate emission filter and the passing light col-
lected by a fast, highly sensitive CCD camera (Little
Joe, SciMeasure, Decatur, Georgia).
Vm mapping
The voltage-sensitive dye RH237 (Grinvald et al. 1982)
(Invitrogen, Carlsbad, California) was used to image
transmembrane voltage. RH-237 was excited with a green
laser (SDL-532-1000T, up to 1000 mW at 532 nm, Shang-
hai Dream Lasers) and emits in the green to red. A long-
pass filter with cutoff wavelength 610 nm was used to
record RH-237 emission.
Bioenergetics analysis
Oxygen consumption rates (OCR) were measured in real
time under basal conditions and in response to indicated
mitochondrial inhibitors using the XFe24 Seahorse Ana-
lyzer (Seahorse Bioscience, North Billerica, MA). The
cells were washed with XF assay medium containing glu-
cose (0.45 g) sodium pyruvate (100 mmol/L) and L-glu-
tamine 4 mmol/L (pH adjusted to 7.4) as per the
manufacturer’s instructions and incubated for 1 h in a
37°C air incubator. An XFe24 plate containing 1 9 105
H9c2 cells/well was transferred to a temperature con-
trolled (37°C) Seahorse (extracellular flux) analyzer and
subjected to an equilibration period. The assay cycle
comprised a 3-min mix, 2-min wait, and 3-min measure
period. After three basal assay cycles, oligomycin
(2 lmol/L) was added by automatic pneumatic injection
to inhibit the ATP synthase and thus approximate the
proportion of respiration used to drive ATP synthesis.
After three more cycles, carbonyl cyanide-4 (trifluo-
romethoxy) phenylhydrazone (FCCP) (2 lmol/L) was
added in the same way to stimulate maximal respiration
in mitochondria by uncoupling ATP synthesis from elec-
tron transport. After another three cycles, rotenone plus
antimycin A (0.5 lmol/L) was added to determine the
nonmitochondrial respiratory rate, which was subtracted
from all other rates. Coupling efficiency was calculated
as the oligomycin-sensitive fraction of mitochondrial res-
piratory activity. The experimental cells were treated with
nsPRP (1:4 nsPRP to cell culture media) for 24 h prior
to analysis.
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Statistical analysis
We used the unpaired two-tailed Student’s t tests to
determine whether two sets of measurements were signifi-
cantly different.
Results
Mouse Langendorff heart
We have previously reported that nsPRP enhances left
ventricular function in the rabbit heart both in vivo and
in situ (Hargrave and Francis 2012; Hargrave 2014). To
establish that this response was not restricted to rabbit,
we analyzed the response of the mouse heart to global
ischemia and reperfusion in the presence or absence of
nsPRP treatment (Fig. 1). Five minutes after reperfusion
was started, +dp/dt was significantly enhanced in nsPRP-
treated hearts and remained so throughout the 60-min
period of reperfusion. These observations are consistent
with our findings in the I/R rabbit model (Hargrave and
Francis 2012; Hargrave 2014).
Analysis of electrical activity in Langendorff
rabbit hearts using optical mapping
Electrical activity diminished as ischemia progressed and
was reduced to noise level in all hearts (n = 7) after
20 min. At this time point, we injected nsPRP in some
hearts (n = 4) and saline in other hearts (n = 2), while
one heart received no injection. Only after 30 min of
ischemia was reperfusion initiated.
Surprisingly, we observed that nsPRP injection
prompted a recovery of electrical activity even before
reperfusion. Figure 2B shows the optically measured elec-
trical signals at the nsPRP injection site at various time
points in a representative example. While electrical activ-
ity had completely ceased after 20 min, it recovered to an
amplitude of about 50% of the control level within 1 min
of nsPRP injection (nsPRP was administered after 20 min
of ischemia). After 30 min, reperfusion was started, and
30 more minutes later, the electrical activity reached and
amplitude of about 75% of the control level. Figure 2C–E
shows amplitude maps obtained at different time points.
The control amplitude map (Panel C, taken before the
onset of ischemia) exhibits strong fluorescence; the spatial
heterogeneities result from nonuniformities in staining,
illumination, and tissue structure. Panel D shows the
amplitude map after 20 min of ischemia; at this point,
virtually all electrical activity has stopped. Panel E shows
a substantial recovery of electrical activity just 1 min later,
after nsPRP has been injected. The region in which we
observe recovery surrounds the injection site, so we con-
clude that recovery occurred in all parts of the heart that
received a sufficient amount of nsPRP. Panel F shows the
activation map of the tissue that has recovered after
nsPRP injection. The map clearly shows that one contigu-
ous wave moves over the whole recovered region. While
conduction is expectedly slow (~ 10 cm/sec), there are no
conduction blocks.
In four hearts in which we injected nsPRP, we always
observed recovery of electrical activity, ranging from 43
to 74% of the control amplitude. Activity generally recov-
ered further during reperfusion to 74–89% of the control
amplitude (except for one heart that deteriorated dramat-
ically during the last ten minutes of ischemia and did not
recover during reperfusion). In contrast, two hearts in
which we injected saline and the heart that did not
receive any injection showed no recovery. The recovery
after reperfusion was to 83–85% of the control amplitude,
comparable to the nsPRP-injected hearts.
Expression of Hsps 27 and 70 and
transfection of H9c2 cells in culture with
siRNA Hsp 70
We analyzed the expression of Hsp 27 and Hsp70 in rab-
bit hearts exposed to nsPRP in vivo. Hearts treated with
nsPRP expressed significantly higher levels of Hsp 27 and
Hsp 70 (Fig. 3) compared to hearts treated with vehicle.
To determine if the decrease in ROS we previously
reported (Hargrave and Francis 2012) was related to the
changes we observed in the heat-shock protein expression,
we transfected H9c2 cells with siRNA Hsp 70. We observed
a 70% decrease in Hsp70 (Fig. 4A). Importantly, cells
300
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*
*
*
%
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Figure 1. nsPRP improves mouse LV function following I/R. Mouse
Langendorff-perfused hearts were treated with 50 µL saline
(vehicle) or nsPRP injected into the myocardium 5 min before
30 min of global ischemia, followed by 60 min of reperfusion. The
data have been normalized to a baseline of 100%. The baseline dp/
dt for the nsPRP hearts was 2526.3 and 2489.2 mmHg for the
vehicle-treated hearts. All data are expressed as means  SEM.
*P < 0.01 from corresponding vehicle group time point. Data are
representative of six vehicle- and three nsPRP-treated hearts.
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transfected with siRNA against Hsp70 produced signifi-
cantly more ROS than cells transfected with the irrelevant
siRNA, even in the presence of nsPRP (Fig. 4B), suggesting
that nsPRP may require Hsp70 for inhibiting ROS forma-
tion. These findings demonstrate an association between
nsPRP-induced HSP expression and ROS inhibition.
Bioenergetics capacity in cultured H9c2 cells
in culture in the presence or absence of
nsPRP
The signature profile of H9c2 mitochondria is shown in
Figure 5A. There was no significant difference in the basal
oxygen consumption rates (OCR) between the nsPRP-trea-
ted and vehicle-treated cells (Fig. 5A and B). Qualitative
and quantitative spare respiratory capacity (Fig. 5A and B,
respectively) and ATP production (Fig. 5C) were signifi-
cantly greater in the nsPRP-treated cells than in the cells
exposed to vehicle. In separate experiments (Fig. 5D), we
exposed H9c2 cells pretreated with nsPRP for 24 h to H2O2
(8 mmol/L) and observed that spare respiratory capacity
still trended higher than that observed in the control cells.
OCR increased in an effort to confront the increased energy
demands. The pretreatment of cultured H9c2 cells with
nsPRP significantly enhanced the “spare respiratory capac-
ity (SRC)” also referred to as “respiratory reserve capacity”
and ATP production in response to the uncoupler FCCP
(Fig. 5A). When oligomycin was added we observed a brief
spike in the extracellular acidification rate (a measure of
glycolysis) under our experimental conditions (data not
shown), suggesting that the XF system was operating
properly.
Discussion
Ischemic–reperfusion injury is a clinically significant event
that is associated with morbidity and mortality (Won
et al. 2010). Therefore, it is critical to develop therapeutic
strategies that improve not only acute survival but the
long-term quality of life. nsPRP is a safe, nonchemical,
autologous therapeutic agent that appears to be effective
in supporting left ventricular function in the ischemic–
reperfused heart. In this study, we have investigated
mechanisms by which nsPRP is capable of enhancing left
ventricular function in the animal heart exposed to ische-
mia and reperfusion.
Heart
preparation
Mirror Diffuser Dichroic mirror
Laser Emission
CCD camera
Control
10 min Isch.
20 min Isch.
20 min Isch. + nsPRP
Activation map20 min ischemia + nsPRP
Electrode
1 cm
0 AU 255 AU 77 msec0 msec
20 min ischemiaBefore ischemia
Reperfusion
25 msec
A
C D E F
B
X
Figure 2. Effect of PRP on electrical activity. (A) Optical mapping setup (see text for details). (B) Action potentials close to the injection site at
various time points during ischemia and reperfusion. Action potential amplitude maps before ischemia (C), after 20 min of ischemia (D), and
1 min after injection of nsPRP (E, injection occurred after 20 min of ischemia, injection site is marked with a red “x”). (F) Activation map for
tissue that has recovered electrical activation after nsPRP injection (1 min after injection). Tissue was stimulated, the electrode position is
marked.
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The use of PRP is an approach that is emerging as a
potential direct method to deliver angiogenic and growth
factors to the ischemic myocardium. Platelet-rich plasma
has provided useful and interesting results (Won et al.
2010; Cheng et al. 2012; Hargrave and Francis 2012; Har-
grave 2014). However, the reproducibility of these results
has been the subject of controversy and skepticism. In
addition, several problems have so far dampened enthusi-
asm for the use of PRP in the cardiovascular system of
patients: (1) injecting a platelet-rich plasma that contains
red blood cells into the heart may lead to thrombi that
can cause stroke or myocardial infarction, (2) thrombin
can cause serious adverse effects in patients and can inter-
fere with the efficacy of PRP, and (3) lack of a mecha-
nism explaining the mode of action of PRP. We recently
modified the production of PRP in two important ways.
First, we found a new way to activate the platelets to
release the growth factors stored in their a granules in the
preparation of PRP by using nanosecond pulsed electric
fields (nsPEFs). Platelets activated using this methodology
appear to preserve the endogenously present antioxidants
(Hargrave and Francis 2012; Hargrave 2014), something
that we did not observe when the platelets were activated
with bovine thrombin. Platelets activated by nsPEFs are
similarly effective functionally to thrombin-activated pla-
telets and in some cases are more effective (Hargrave
2014), and are without the adverse effects of thrombin.
Second, we have shown that by using the supernatant of
nsPRP, we can eliminate cells (the causes for thrombi)
and still retain effectiveness (Hargrave 2014).
There are several mechanisms of myocardial reperfu-
sion injury. However, two major mechanisms are oxida-
tive stress (primarily oxygen-free radicals) and endothelial
dysfunction. Although it is unlikely that any one single
pathologic mechanism causes I/R injury, the sum of mul-
tiple events, occurring simultaneously, increases the
chance of irreversible damage to the myocardium. For
example, ischemia and reperfusion are associated with
increased ROS levels, vascular dysfunction, and mitochon-
drial damage. Intriguingly, preservation of these antioxi-
dants was not observed in the PRP prepared using bovine
thrombin as the platelet activator (Hargrave 2014). Here,
we show that the partial inhibition of ROS by nsPRP may
be mediated via the heat-shock proteins (Fig. 3B) and by
stabilization of the mitochondrial membrane.
The reduction of ROS levels in nsPRP-treated cells was
not only observed in H9c2 cells but also in HUVEC cells
(Hargrave 2014), and suggests that lower ROS levels may
protect the vascular endothelium as well as cardiomy-
ocytes from extensive damage under I/R conditions,
thereby preserving function possibly via regulation of the
heat-shock proteins.
The enhanced left ventricular function we observed in
the globally ischemic/reperfused mouse Langendorff
preparation is consistent with what we (Hargrave and
Francis 2012; Hargrave 2014) and others (Cheng et al.
2012) have reported. However, how nsPRP enhances LV
function is unclear. In this study, we demonstrated that
nsPRP treatment of I/R heart tissue in the rabbit is asso-
ciated with increased expression of two cardioprotective
proteins, Hsp 27 and Hsp 70. Hsp 27 has been shown to
be antiapoptotic and cardioprotective for myocytes under
stressful conditions such as I/R (Blunt et al. 2007). Blunt
et al. have shown that H2O2 activation of Hsp 27 protects
desmin from calpain proteolysis in rat ventricular myo-
cytes (Blunt et al. 2007). Although Hsp 27 is a potent
protein, its low transduction efficiency and instability,
and short half-life in the body limits its in vivo applica-
tion (Christina et al. 2012). Hsp 70 overexpression of in
H9c2 cells increase the resistance to an ischemic stress. In
1996, Dillman et al. showed that occlusion of the LAD in
dog hearts induced the expression of Hsp 70. We have
shown that the transient ligation of the LAD followed by
14 days of reperfusion in rabbits is associated with
increased expression of Hsps 27 and 70 (Dillmann et al.
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1986). Although it seems likely that expression of the
Hsps may have occurred earlier than the 14-day time per-
iod, we only have data supporting a significant increase
in expression on day 14 of the experiment. These data
suggest one possible explanation for the enhanced LV
function. Following ischemic events such as CABG sur-
gery, the stress-inducible heat-shock protein Hsp70 has
been detected in myocardial cells (Braunwald and Kloner
1982; Dillmann et al. 1986; Chen and Knowlton 2011). In
addition, studies show that CABG surgery and ischemic–
reperfusion injury are associated with increased produc-
tion of ROS (Murphy 2004; Rosca and Hoppel 2010),
with an ensuing decreased antioxidant defense. The
upregulation of expression of Hsp27 and Hsp70 in the
presence of nsPRP may, at least in part, explain the
enhanced LV function during I/R and may suggest that a
reduction in ROS levels (mediated via Hsp) coupled with
the presence of the antioxidants CAT and SOD in the tis-
sue, prevent ROS from reaching levels that overwhelm the
endogenous free radical scavenging systems thereby
reducing ROS damage to myocytes and mitochondria.
Our findings are consistent with the ischemia and reper-
fusion associated with CABG surgery when stress-induci-
ble Hsp70 has been detected in myocardial cells (Murphy
2004; Rosca and Hoppel 2010).
In this study, we also demonstrate that the spare respi-
ratory capacity in H9c2 cells in culture increases in the
cells treated with nsPRP. Mitochondrial dysfunction
occurs in ischemic heart disease (Ferrari and Williams
1986; Murphy 2004; Brady et al. 2006). Under conditions
such as I/R, the heart requires additional cellular energy
in response to stress or increased workload. If the reserve
respiratory capacity of the ventricular myocytes is not suf-
ficient to provide the required ATP, cell death can occur.
nsPRP may function to protect this spare respiratory
capacity (SRC), and thereby reduce cell death. nsPRP-
treated H9c2 cells have an enhanced SRC compared to
cells treated with vehicle. SRC is a measure of the cell’s
ability to respond to increased energy demand. It is the
extra capacity available in myocytes to produce energy in
response to increased stress caused by I/R and as such is
involved in cell survival. Heart cells, like other cell types
operate at a basal level that only requires a part of their
total bioenergetics capability. The difference between ATP
produced by oxidative phosphorylation at basal and that
at maximal activity is called the SRC.
We measured the bioenergetic capacity of H9c2 cells in
culture to determine whether they use the SRC in
response to stress caused by ROS. We observed that
intact H9c2 had a substantial capacity to respond to
increasing energy demand under basal conditions and in
the presence of increased ROS. However, the reason for
this response is unclear. It is possible that cell biosynthe-
sis may have increased in the cells treated with nsPRP.
We feel that this is unlikely since the data were normal-
ized to the cell number per well with the cell number/
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well remaining fairly consistent between nsPRP- and
vehicle-treated cells. Ferrari et al. reported that although
there was a slight reduction in the number of mitochon-
dria isolated from I/R hearts, there were only small func-
tional changes observed, suggesting the presence of a
“reserve function in mitochondria extracted from severely
damaged cardiac tissue (Ferrari and Williams 1986).
Whatever the mechanism, our studies clearly point to
enhancement of the SRC in nsPRP-treated cells in vitro,
and enhanced LV work function in the rabbit in vivo
and the Langendorff mouse and rabbit hearts in situ fol-
lowing I/R. This increased cardiac capacity may make the
heart less vulnerable to bioenergetic exhaustion and
thereby decrease the risk of inducing cell death and organ
failure.
The ischemic myocardium is prone to increased irri-
tability which can increase the incidence of arrhythmias
or sudden cardiac death (Brady et al. 2006). The role that
the mitochondria exert in controlling cardiac excitation
contraction coupling, excitability, and arrhythmias is not
very clear. nsPRP appears to reduce mitochondrial
depolarization in both H9c2 and HUVEC cells in culture
(Hargrave 2014) suggesting that it in some way stabilizes
myocyte and mitochondrial membranes. nsPRP may pro-
vide cardioprotection by altering the pathologic electrical
activity of the heart, thereby reducing the frequency of
arrhythmias. Using optical mapping, we show that LV tis-
sue exposed to global ischemia and treated with nsPRP
prior to reperfusion recovered excitability within 1 min
in the region injected with nsPRP (but not after the injec-
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*P < 0.001 for FCCP injection (B) and ATP production (C). Mito stress analysis was performed in the presence or absence of nsPRP
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tion of saline). The recovered tissue sustained smoothly
propagating waves of excitation, raising the possibility
that nsPRP injection can immediately restore (partial)
cardiac function in a clinical setting.
nsPRP may also reduce the irritability of the heart and
decrease the possibility of arrhythmias. The mechanism
involved is currently under investigation. However,
arrhythmogenesis has long been associated with the pres-
ence and activation of ion channels (Beavis and Garlid
1987). There are many ion channels located in the inner
membrane of the mitochondria. The Ca2+ uniporter is
the primary route for Ca2+ entry into the mitochondrial
matrix, an event necessary for stimulation of oxidative
phosphorylation (Akar et al. 2005; Piot et al. 2008). How-
ever, mitochondrial Ca2+ overload, as that thought to
occur during I/R, can trigger opening of the mPTP. The
K+ channels (mitoKATP, mitoKCa2+, voltage-activated
K+) are thought to be cytoprotective (Piot et al. 2008)
although there is controversy regarding the specificity of
certain K+ channel openers and the mechanisms used by
these channels to convey protection. There are also chan-
nels that are associated with mitochondrial dysfunction.
The mPTP channel is thought to be activated by oxidative
stress, Ca2+, and depolarization. The opening of this
channel during I/R (more so during reperfusion) is linked
to triggering apoptosis and Ca2+ overload, signaling irre-
versible mitochondrial damage (Lyon et al. 2010). The
mitochondrial inner membrane also contains several
anion-selective channels, many with undetermined roles.
Of key importance is the IMAC. This channel is reported
to mediate the efflux of O2 (Brown et al. 2008) and
makes it an attractive candidate in the regulation of cellu-
lar bioenergetics and redox control (Paky et al. 1993). We
speculate that nsPRP may prevent the opening of the
mPTP channel through its ability to reduce ROS levels,
thereby reducing mitochondrial depolarization and pre-
serving mitochondrial function.
nsPRP contains a wealth of substances that may affect
cardiac function. In the studies described in this work, we
used an autologous platelet-rich plasma supernatant
formed by activating the platelets to release their proteins
and other substances with nanosecond pulsed electric
fields. This protein mixture was injected into the
myocardium of the heart and no doubt affected cardiac
mechanical and electrical performance. For example, ATP
possibly released from the dense granules of the platelets
may serve as a neurotransmitter or in cell-to-cell communi-
cation signaling in inflammation and immune responses
(Brybsticj 2006). Adenosine may work to precondition the
cardiac tissue to the actions of other proteins (Jx and Chen
2015). Glutathione may serve to support the endogenous
antioxidant scavenging system so that this system is not
overwhelmed by the ROS produced during reperfusion
(Salonen et al. 1991).
In summary, we have found that nsPRP enhances left
ventricular dp/dt in the Langendorff mouse heart and that
its injection into the Langendorff rabbit heart is associ-
ated with a faster recovery of electrical activity, therefore
reducing the likelihood of arrhythmias. nsPRP also
increased the expression of Hsps 27 and 70, with Hsp 70
being necessary for the reduction in ROS levels previously
reported. nsPRP also enhances the spare respiratory
capacity of mitochondria in the presence and absence of
H2O2, providing the heart with increased cardiac capacity,
and making it less vulnerable to bioenergetic exhaustion
during I/R. Collectively, these changes function to protect
the heart and enhance performance.
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